Literature DB >> 18255339

Leishmania: conserved evolution--diverse diseases.

Miriam A Lynn1, W Robert McMaster.   

Abstract

The landmark completion of the Leishmania major genome sequence and the recent publication of the L. infantum and L. braziliensis genomes revealed the surprising result that, although separated by 15-50 million years of evolution, the Leishmania genomes are highly conserved and have less than 1% species-specific genes. Yet, these three species of Leishmania cause distinctive and diverse diseases in humans. Here, we discuss these findings together with recent microarray and proteomics studies and highlight their importance in understanding Leishmania disease phenotypes.

Entities:  

Mesh:

Year:  2008        PMID: 18255339     DOI: 10.1016/j.pt.2007.11.006

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  14 in total

1.  Variation in clinical presentation and genotype of causative Leishmania major strain in cutaneous leishmaniasis in north and south Afghanistan.

Authors:  Pieter-Paul A M van Thiel; Tom van Gool; William R Faber; Tjalling Leenstra; Piet A Kager; Aldert Bart
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

Review 2.  UDP-sugar pyrophosphorylase: a new old mechanism for sugar activation.

Authors:  Leszek A Kleczkowski; Daniel Decker; Malgorzata Wilczynska
Journal:  Plant Physiol       Date:  2011-03-28       Impact factor: 8.340

Review 3.  The immunological, environmental, and phylogenetic perpetrators of metastatic leishmaniasis.

Authors:  Mary-Anne Hartley; Stefan Drexler; Catherine Ronet; Stephen M Beverley; Nicolas Fasel
Journal:  Trends Parasitol       Date:  2014-06-20

4.  The magnitude of CD4(+) T-cell activation rather than TCR diversity determines the outcome of Leishmania infection in mice.

Authors:  L Xin; J L Wanderley; Y Wang; D A Vargas-Inchaustegui; L Soong
Journal:  Parasite Immunol       Date:  2011-03       Impact factor: 2.280

5.  LeishCyc: a biochemical pathways database for Leishmania major.

Authors:  Maria A Doyle; James I MacRae; David P De Souza; Eleanor C Saunders; Malcolm J McConville; Vladimir A Likić
Journal:  BMC Syst Biol       Date:  2009-06-05

6.  Perspectives From Systems Biology to Improve Knowledge of Leishmania Drug Resistance.

Authors:  Elvira Cynthia Alves Horácio; Jéssica Hickson; Silvane Maria Fonseca Murta; Jeronimo Conceição Ruiz; Laila Alves Nahum
Journal:  Front Cell Infect Microbiol       Date:  2021-04-30       Impact factor: 5.293

7.  Trypanosomatid comparative genomics: Contributions to the study of parasite biology and different parasitic diseases.

Authors:  Santuza M Teixeira; Rita Márcia Cardoso de Paiva; Monica M Kangussu-Marcolino; Wanderson D Darocha
Journal:  Genet Mol Biol       Date:  2012-01-20       Impact factor: 1.771

8.  SOLiD™ sequencing of genomes of clinical isolates of Leishmania donovani from India confirm leptomonas co-infection and raise some key questions.

Authors:  Neeloo Singh; Surendra Chikara; Shyam Sundar
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

9.  TLR1/2 activation during heterologous prime-boost vaccination (DNA-MVA) enhances CD8+ T Cell responses providing protection against Leishmania (Viannia).

Authors:  Asha Jayakumar; Tiago M Castilho; Esther Park; Karen Goldsmith-Pestana; Jenefer M Blackwell; Diane McMahon-Pratt
Journal:  PLoS Negl Trop Dis       Date:  2011-06-14

Review 10.  Leishmania RNA virus: when the host pays the toll.

Authors:  Mary-Anne Hartley; Catherine Ronet; Haroun Zangger; Stephen M Beverley; Nicolas Fasel
Journal:  Front Cell Infect Microbiol       Date:  2012-07-12       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.